Mitsuyoshi Azuma

2.0k total citations
71 papers, 1.7k citations indexed

About

Mitsuyoshi Azuma is a scholar working on Molecular Biology, Cell Biology and Ophthalmology. According to data from OpenAlex, Mitsuyoshi Azuma has authored 71 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 41 papers in Cell Biology and 17 papers in Ophthalmology. Recurrent topics in Mitsuyoshi Azuma's work include Calpain Protease Function and Regulation (39 papers), Connexins and lens biology (33 papers) and Glaucoma and retinal disorders (11 papers). Mitsuyoshi Azuma is often cited by papers focused on Calpain Protease Function and Regulation (39 papers), Connexins and lens biology (33 papers) and Glaucoma and retinal disorders (11 papers). Mitsuyoshi Azuma collaborates with scholars based in United States, Japan and France. Mitsuyoshi Azuma's co-authors include Thomas R. Shearer, Chiho Fukiage, Emi Nakajima, Takeshi Nakajima, Yoshiyuki Tamada, Takayuki Oka, Hong Ma, Yukuo Yoshida, Yoshikuni Nakamura and M. Shih and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Mitsuyoshi Azuma

70 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsuyoshi Azuma United States 27 1.1k 790 399 266 189 71 1.7k
Raju V. S. Rajala United States 30 1.7k 1.5× 339 0.4× 631 1.6× 384 1.4× 107 0.6× 98 2.2k
Iok-Hou Pang United States 21 1.5k 1.3× 397 0.5× 1.3k 3.1× 265 1.0× 183 1.0× 40 2.4k
Natik Piri United States 22 1.2k 1.1× 174 0.2× 597 1.5× 324 1.2× 83 0.4× 52 1.5k
Wojciech Kędzierski United States 17 636 0.6× 176 0.2× 231 0.6× 186 0.7× 79 0.4× 43 1000
Rafal Farjo United States 17 932 0.8× 114 0.1× 329 0.8× 201 0.8× 62 0.3× 35 1.2k
Iván Conte Italy 24 1.1k 0.9× 244 0.3× 203 0.5× 125 0.5× 63 0.3× 50 1.5k
Cassandra L. Schlamp United States 24 1.6k 1.4× 122 0.2× 1.2k 2.9× 352 1.3× 70 0.4× 42 2.2k
Javier Sancho-Pellúz Spain 18 954 0.8× 78 0.1× 354 0.9× 208 0.8× 53 0.3× 33 1.2k
Yasuhiro Nakagami Japan 20 577 0.5× 203 0.3× 74 0.2× 206 0.8× 296 1.6× 44 1.3k
Francisco D. Rodríguez Spain 16 769 0.7× 83 0.1× 378 0.9× 270 1.0× 97 0.5× 50 1.3k

Countries citing papers authored by Mitsuyoshi Azuma

Since Specialization
Citations

This map shows the geographic impact of Mitsuyoshi Azuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuyoshi Azuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuyoshi Azuma more than expected).

Fields of papers citing papers by Mitsuyoshi Azuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuyoshi Azuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuyoshi Azuma. The network helps show where Mitsuyoshi Azuma may publish in the future.

Co-authorship network of co-authors of Mitsuyoshi Azuma

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuyoshi Azuma. A scholar is included among the top collaborators of Mitsuyoshi Azuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuyoshi Azuma. Mitsuyoshi Azuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nakagami, Yasuhiro, et al.. (2020). NFE2L2 activator RS9 protects against corneal epithelial cell damage in dry eye models. PLoS ONE. 15(4). e0229421–e0229421. 6 indexed citations
3.
Ohtori, Akira, et al.. (2017). In Silico Ocular Pharmacokinetic Modeling: Delivery of Topical FK962 to Retina. Journal of Ocular Pharmacology and Therapeutics. 33(7). 556–566. 7 indexed citations
4.
Fujii, Atsuko, Thomas R. Shearer, & Mitsuyoshi Azuma. (2015). Galectin-3 enhances extracellular matrix associations and wound healing in monkey corneal epithelium. Experimental Eye Research. 137. 71–78. 28 indexed citations
5.
Suzuki, Rie, Takayuki Oka, Yoshiyuki Tamada, Thomas R. Shearer, & Mitsuyoshi Azuma. (2014). Degeneration and Dysfunction of Retinal Neurons in Acute Ocular Hypertensive Rats: Involvement of Calpains. Journal of Ocular Pharmacology and Therapeutics. 30(5). 419–428. 9 indexed citations
6.
Fujii, Atsuko, Thomas R. Shearer, & Mitsuyoshi Azuma. (2012). Galectin-3 Facilitates Epithelial Wound Healing in Explanted Monkey Corneas. Investigative Ophthalmology & Visual Science. 53(14). 3540–3540. 1 indexed citations
7.
Sasaki, Ayano, Yoshiyuki Tamada, Thomas R. Shearer, & Mitsuyoshi Azuma. (2012). Galection-3 Facilitates Corneal Epithelial Wound Healing In A Rat Model Of Dry Eye. Investigative Ophthalmology & Visual Science. 53(14). 2359–2359. 1 indexed citations
8.
Azuma, Mitsuyoshi, et al.. (2010). Patient Selection Criteria for Pilot Studies on Amelioration of Non-Neovascular Age-Related Macular Degeneration. Journal of Ocular Pharmacology and Therapeutics. 26(4). 367–371. 4 indexed citations
9.
Ma, Hong, et al.. (2009). Calpain Inhibitor SNJ-1945 Attenuates Events Prior to Angiogenesis in Cultured Human Retinal Endothelial Cells. Journal of Ocular Pharmacology and Therapeutics. 25(5). 409–414. 23 indexed citations
10.
Fukiage, Chiho, et al.. (2006). PACAP Induces Neurite Outgrowth in Cultured Trigeminal Ganglion Cells and Recovery of Corneal Sensitivity After Flap Surgery in Rabbits. American Journal of Ophthalmology. 143(2). 255–262.e1. 41 indexed citations
11.
Nakajima, Emi, et al.. (2005). Contribution of ROCK in Contraction of Trabecular Meshwork: Proposed Mechanism for Regulating Aqueous Outflow in Monkey and Human Eyes. Journal of Pharmaceutical Sciences. 94(4). 701–708. 96 indexed citations
12.
Tamada, Yoshiyuki, et al.. (2005). Calpain‐dependent α‐fodrin cleavage at the sarcolemma in muscle diseases. Muscle & Nerve. 32(3). 303–309. 18 indexed citations
13.
Oka, Takayuki, Thomas R. Shearer, & Mitsuyoshi Azuma. (2004). Involvement of cyclooxygenase-2 in rat models of conjunctivitis. Current Eye Research. 29(1). 27–34. 33 indexed citations
14.
Nakajima, Takeshi, Emi Nakajima, Chiho Fukiage, Mitsuyoshi Azuma, & Thomas R. Shearer. (2002). Differential Gene Expression in the Lens Epithelial Cells from Selenite Injected Rats. Experimental Eye Research. 74(2). 231–236. 25 indexed citations
15.
Fukiage, Chiho, Emi Nakajima, Hong Ma, Mitsuyoshi Azuma, & Thomas R. Shearer. (2002). Characterization and Regulation of Lens-specific Calpain Lp82. Journal of Biological Chemistry. 277(23). 20678–20685. 32 indexed citations
16.
Waki, Mitsunori, Yukuo Yoshida, Takayuki Oka, & Mitsuyoshi Azuma. (2001). Reduction of intraocular pressure by topical administration of an inhibitor of the Rho-associated protein kinase. Current Eye Research. 22(6). 470–474. 93 indexed citations
17.
Tamada, Yoshiyuki, Chiho Fukiage, K Mizutani, et al.. (2001). Calpain inhibitor, SJA6017, reduces the rate of formation of selenite cataract in rats. Current Eye Research. 22(4). 280–285. 27 indexed citations
18.
Nakamura, Yoshikuni, Chiho Fukiage, Mitsuyoshi Azuma, & Thomas R. Shearer. (2001). Calpain-Induced Light Scattering in Young Rat Lenses is Enhanced by UV-B. Journal of Ocular Pharmacology and Therapeutics. 17(1). 47–58. 2 indexed citations
19.
Ma, Hong, Chiho Fukiage, Yung Hae Kim, et al.. (2001). Characterization and Expression of Calpain 10. Journal of Biological Chemistry. 276(30). 28525–28531. 98 indexed citations
20.
Tamada, Yoshiyuki, et al.. (2000). Involvement of Cysteine Proteases in bFGF-Induced Angiogenesis in Guinea Pig and Rat Cornea. Journal of Ocular Pharmacology and Therapeutics. 16(3). 271–283. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raju V. S. Rajala Breakdown of academic impact, for papers by Iok-Hou Pang Breakdown of academic impact, for papers by Natik Piri Breakdown of academic impact, for papers by Wojciech Kędzierski Breakdown of academic impact, for papers by Rafal Farjo Breakdown of academic impact, for papers by Iván Conte Breakdown of academic impact, for papers by Cassandra L. Schlamp Breakdown of academic impact, for papers by Javier Sancho-Pellúz Breakdown of academic impact, for papers by Yasuhiro Nakagami Breakdown of academic impact, for papers by Francisco D. Rodríguez
Rankless by CCL
2026